Phase II study of 1,2,4-triglycidyl urasol (TGU) in advanced soft tissue sarcoma. A trial of the EORTC Soft Tissue and Bone Sarcoma Cooperative Group. (Record no. 3684029)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01475 a2200421 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250512064622.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 198801s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0277-5379 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/0277-5379(87)90129-5 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Rouëssé, J G |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 19880114 |
245 00 - TITLE STATEMENT | |
Title | Phase II study of 1,2,4-triglycidyl urasol (TGU) in advanced soft tissue sarcoma. A trial of the EORTC Soft Tissue and Bone Sarcoma Cooperative Group. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | European journal of cancer & clinical oncology |
Date of publication, distribution, etc. | Sep 1987 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1413-4 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Evaluation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Leukopenia |
General subdivision | chemically induced |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sarcoma |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Soft Tissue Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Thrombocytopenia |
General subdivision | chemically induced |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Triazoles |
General subdivision | adverse effects |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | van Oosterom, A T |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Capellaere, P |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kerbrat, P |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | van Coninge, C J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Thomas, D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Benshahar, D |
773 0# - HOST ITEM ENTRY | |
Title | European journal of cancer & clinical oncology |
Related parts | vol. 23 |
-- | no. 9 |
-- | p. 1413-4 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/0277-5379(87)90129-5">https://doi.org/10.1016/0277-5379(87)90129-5</a> |
Public note | Available from publisher's website |
No items available.